Quantcast
Last updated on April 17, 2014 at 15:50 EDT

Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, Cerebral Angioplasty Balloons] – Global Trends & Competitive Analysis – 2017

April 15, 2013

DUBLIN, April 15, 2013 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/wmdxqt/neurovascularinte) has announced the
addition of the “Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid
Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty
Balloons] – Global Trends & Competitive Analysis to 2017″ report to their offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

Neurointerventional radiology or endovascular neurosurgery refers to special minimally
invasive procedures to diagnose and treat vascular disorders of the brain and spine. With
the help of advanced imaging for guidance, neurointerventionalists or neurosurgeons use
microcatheters (tiny tubes) to treat many complex disorders. Normally these disorders are
treated either by closing (embolization) or opening (recanalization) the abnormal vessels.
The neurointerventional device market encompasses neurothrombectomy devices
(suction/aspiration device, clot retriever, and snare device), cerebral angiography and
stenting system (carotid stent, and embolic protection system), aneurysm coiling devices
(platinum coil, liquid embolic agents, and flow diversion device) and support devices
(microcatheter, and microguidewire).

The neurointerventional devices market encompasses neurothrombectomy devices
(suction/aspiration device, clot retriever, and snare device), cerebral angiography and
stenting system (carotid stent, and embolic protection system), aneurysm coiling devices
(platinum coil, liquid embolic agents, and flow diversion device) and support devices
(microcatheter, and microguidewire).

The global neurointerventional devices market is estimated to be $1,248.5 million in
2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm
Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts
for the largest share of the global neurointerventional devices market, followed by
support devices cerebral balloon angioplasty & stenting systems and neurothrombectomy
devices in 2012.

The major driving factor for these markets involves gradual technological evolution,
growing ageing and obese population, rising patient pool for ischemic and hemorrhagic
stroke and increasing demand for minimally invasive surgical procedures. Growing GDP and
healthcare allocation are making developing countries in Asia and Latin America affordable
to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical
trial data is favoring the interventional procedure over neurosurgery as it offers limited
hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection
in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America dominates the overall neurointerventional devices market. Asia-Pacific
market including India, China and Japan, and Latin America market are expected to grow at
a higher pace due to the effect of growing GDP and purchasing capability of healthcare
institutions in those countries. Coiling procedure and flow diversion have gained
popularity in the Asia-Pacific and Latin American market.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Neurointerventional Devices Market, By Techniques

5 Global Neurointerventional Devices Market, By Products

6 Geographic Analysis

7 Competitive Landscape

8 Company Profiles

Companies Mentioned

– Abbott Laboratories

– Bayer Ag

– Coaxia, Inc.

– Covidien, Plc

– Johnson & Johnson

– Merit Medical Systems, Inc.

– Neurointerventional Therapeutics, Inc. (Nit)

– Nfocus Neuromedical, Inc.

– Penumbra, Inc.

– Reverse Medical Corporation

– Stryker Corporation

– Terumo Corporation

– Valor Medical, Inc.

– W.L.Gore & Associates, Inc.

For more information visit

http://www.researchandmarkets.com/research/wmdxqt/neurovascularinte

        Research and Markets
        Laura Wood, Senior Manager.
        press@researchandmarkets.com
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +353-1-481-1716
        Sector: Healthcare and Medical Devices, Pharmaceuticals


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire